Department of Emergency - Urgency

Acute Cardiac Care

Quick Facts

The Acute Cardiac Care Unit comprises 25 beds in 12 rooms and is closely connected with E.R. because it exclusively admits patients from this Unit who do not require admission to the Cardiology Intensive Care Unit.

The Acute Cardiac Care Unit consists of 25 beds distributed in 12 rooms.
It is closely interconnected with the Emergency Room because the Acute Cardiac Care Unit only welcomes patients from ER who do not require admission to the Intensive Cardiac Care Unit (UTIC). In this Unit more than 1100 admissions have been made in the last year.

The most frequently treated pathologies are represented by heart failure, unstable angina, myocardial infarctions without overplanning of the ST tract (NSTEMI), tachy or brady arrhythmias. In some cases, the transfer is carried out to specific inpatient wards (Cardiosurgery, Invasive Cardiology) for those patients who need further therapeutic procedures, after the first treatment and the initial diagnosis.

Research Activities

  • The research activity is mainly aimed at the study of the problems related to ischemic heart disease both in the identification of new myocardial ischemia's markers and in the testing of new drugs. The Unit participates in numerous International Multicenter Phase II and III Trials, which study the safety and effectiveness of new antithrombotic drugs used in the context of acute coronary heart syndromes and atrial fibrillation.

Other Activities

  • Educational activities

    The Unit collaborates with the University of Milan, allowing students to attend, in rotation, the E.R. and the Acute Cardiac Care Unit for the purpose of receiving specific training. The Unit also provides the logistics and tutors necessary for the preparation of the theses for both undergraduates and post-graduate junior specialists.

    National and international scientific activities

    The Unit participates in various congress of the main Italian and European scientific societies. They are also involved in the management of numerous phase II and phase III international trials on the treatment of acute coronary syndromes and atrial fibrillation.